Pancreatic Cancer Research

ResearcherHubei University of Arts and ScienceActive in the last 2 years

Yu Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1348-8992; OpenAlex author ID A5100402105. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. TRIM16 and PRC1 Are Involved in Pancreatic Cancer Progression and Targeted by Delphinidin. Co-author DOI 10.1111/cbdd.70026↗
  2. LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis. Last author DOI 10.1016/j.tranon.2021.101088↗
  3. Corrigendum to " LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis" [Translational Oncology 14(7):101088]. Last author DOI 10.1016/j.tranon.2021.101143↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zixiang Zhang · 2 shared papers, 2021 · strength 0.32
  2. Hongyan Zhu · 2 shared papers, 2021 · strength 0.32
  3. Manyu Chen · 1 shared paper, 2024 · strength 0.26
  4. Donghua Wang · 1 shared paper, 2024 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.